<p>Continued innovation and investment is vital to maintaining the U.S.&apos;s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.</p><h1>Mentioned</h1><ul><li>Sandra Barbosu, “<a href='https://itif.org/publications/2024/11/15/harnessing-ai-to-accelerate-innovation-in-the-biopharmaceutical-industry/'>Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry</a>,” (ITIF, November 2024)</li><li> Richard Fleischer, dir. <em>Fantastic Voyage, </em>(20th Century-Fox, 1966).</li></ul><h1>Related</h1><ul><li>Stephen Ezell and Meghan Ostertag, “<a href='https://itif.org/publications/2025/06/16/bayh-dole-acts-role-in-stimulating-university-led-regional-economic-growth/'>The Bayh-Dole Act’s Role in Stimulating University-Led Regional Economic Growth</a>,” (ITIF, June 2025)</li></ul><p> </p>

<description>&lt;p&gt;Continued innovation and investment is vital to maintaining the U.S.&amp;apos;s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.&lt;/p&gt;&lt;h1&gt;Mentioned&lt;/h1&gt;&lt;ul&gt;&lt;li&gt;Sandra Barbosu, “&lt;a href='https://itif.org/publications/2024/11/15/harnessing-ai-to-accelerate-innovation-in-the-biopharmaceutical-industry/'&gt;Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry&lt;/a&gt;,” (ITIF, November 2024)&lt;/li&gt;&lt;li&gt; Richard Fleischer, dir. &lt;em&gt;Fantastic Voyage, &lt;/em&gt;(20th Century-Fox, 1966).&lt;/li&gt;&lt;/ul&gt;&lt;h1&gt;Related&lt;/h1&gt;&lt;ul&gt;&lt;li&gt;Stephen Ezell and Meghan Ostertag, “&lt;a href='https://itif.org/publications/2025/06/16/bayh-dole-acts-role-in-stimulating-university-led-regional-economic-growth/'&gt;The Bayh-Dole Act’s Role in Stimulating University-Led Regional Economic Growth&lt;/a&gt;,” (ITIF, June 2025)&lt;/li&gt;&lt;/ul&gt;&lt;p&gt; &lt;/p&gt;</description>

Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation. MentionedSandra Barbosu, “Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry,” (ITIF, November 2024) Richard Flei...

Innovation Files: Where Tech Meets Public Policy

mRNA and the Future of Personalized Medicine, With Andrew Geall and Deborah Barbara

mRNA and the Future of Personalized Medicine, With Andrew Geall and Deborah Barbara

Description